Company page

Marinomed Biotech Ag

Marinomed Biotech AG, trading under the ticker MARI, is a public company based in Austria with a market capitalization of approximately €26.8 million. The company focuses on developing innovative therapies for viral infections and autoimmune diseases. Marinomed is known for its proprietary technology platforms, which aim to enhance treatment options in the biopharmaceutical sector.